Abstract
Nicotine has been shown in a variety of studies to improve memory performance. The cognitive effects of nicotine are particularly important with regard to schizophrenia. In the current studies nicotine interactions with three different antipsychotic drugs, haloperidol, clozapine and risperidone, were assessed with regard to memory function. Female Sprague-Dawley rats were trained on the radial-arm maze to asymptotic levels of choice accuracy. They were then administered nicotine alone or in combination with haloperidol, clozapine or risperidone. Acute haloperidol (0.04 mg/kg) did not by itself affect memory performance. Co-administration of haloperidol with nicotine, however, decreased memory performance compared with nicotine administration in isolation. Acute clozapine (1.25 and 2.5 mg/kg) caused a significant memory impairment, an effect reversed by acute nicotine co-treatment. Risperidone (0.05 mg/kg), like haloperidol, did not by itself affect memory performance. Risperidone co-administration with nicotine, however, did significantly attenuate the improvement caused by nicotine administration in isolation. The similar interaction of haloperidol and risperidone with nicotine may be due to their common action of blocking D2 receptors, a mechanism of action not shared by clozapine. In contrast to the interaction of nicotine with haloperidol or risperidone, nicotine effectively reversed clozapine-induced memory impairment. These studies demonstrate interactions between nicotine and antipsychotic drugs in terms of memory, which may have important impacts on the treatment of schizophrenia.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Brazell MP, Mitchell SN, Joseph MH, Gray JA . (1990): Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3.4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with caudate-putamen. Neuropharmacology 29: 1177–1185
Buccafusco JJ, Prendergast MA, Terry AV, Jackson WJ . (1996): Cognitive effects of nicotinic cholinergic receptor agonists in nonhuman primates. Drug Develop Res. 38: 196–203
Buchanan RW, Holstein C, Breier A . (1994): The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry 36: 717–725
el-Bizri H, Clarke PBS . (1994): Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo. Br J Pharmacol 111: 414–418
Grady S, Marks MJ, Wonnacott S, Collins AC . (1992): Characterization of nicotinic receptor-mediated H3dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59: 848–856
Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY . (1993): Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 34: 702–712
Hertel P, Nomikos GG, Iurlo M, Svensson TH . (1996): Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology (Berl) 124: 74–86
Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T . (1999): Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci USA 96: 13432–13437
Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA . (1986): Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143: 993–997
Kathmann M, Schlicker E, Gothert M . (1994): Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors. Psychopharmacology (Berl) 116: 464–468
Lee MA, Jayathilake K, Meltzer HY . (1999): A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophr Res 37: 1–11
Levin E, Wilson W, Rose J, McEvoy J . (1996a): Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15: 429–436
Levin ED . (1988): Psychopharmacological effects in the radial-arm maze. Neurosci Biobehav Rev 12: 169–175
Levin ED . (1992): Nicotinic systems and cognitive function. Psychopharmacology (Berl) 108: 417–431
Levin ED . (1997): Chronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat. Pharmacol Biochem Behav 58: 899–902
Levin ED, Bradley A, Addy N, Sigurani N . (2002): Hippocampal α7 and α4β2 nicotinic receptors and working memory. Neuroscience 104: 757–765
Levin ED, Briggs SJ, Christopher NC, Rose JE . (1993): Chronic nicotinic stimulation and blockade effects on working memory. Behav Pharmacol 4: 179–182
Levin ED, Eisner B . (1994): Nicotine interactions with D1 and D2 agonists: Effects on working memory function. Drug Dev Res 31: 32–37
Levin ED, Galen D, Ellison GD . (1987): Chronic haloperidol effects on radial arm maze performance and oral movements in rats. Pharmacol Biochem Behav 26: 1–6
Levin ED, McGurk SR, Rose JE, Butcher LL . (1990): Cholinergic-dopaminergic interactions in cognitive performance. Behav Neural Biol 54: 271–299
Levin ED, Rose JE . (1992): Cognitive effects of D1 and D2 interactions with nicotinic and muscarinic systems. In Levin ED, Decker MW, Butcher LL (eds), Neurotransmitter Interactions and Cognitive Function. Boston, Berkhäuser, pp 144–158
Levin ED, Rose JE, Lippelio P, Robinson J . (1996b): Nicotine and neurobehavioral function. Drug Develop Res 38: 135
Levin ED, Russell RW . (1992): Nicotinic-muscarinic interactions in cognitive function. In Levin ED, Decker MW, Butcher LL (eds), Neurotransmitter Interactions and Cognitive Function. Boston, Berkhäuser, pp 183–195
Levin ED, Simon BB . (1998): Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138: 217–230
Leysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, Janssen PA . (1988): Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 247: 661–670
Liegeois J, Eyrolles L, Bruhwyler J, Delarge J . (1998): Dopamine D4 receptors: a new opportunity for research on schizophrenia. Curr Med Chem 5: 77–100
Matsubara S, Matsubara R, Kusumi I, Koyama T, Yamashita I . (1993): Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Ther 265: 498–508
McGurk SR, Levin ED, Butcher LL . (1989a): Nicotinic-dopaminergic relationships and radial-arm maze performance in rats. Behav Neural Biol 52: 78–86
McGurk SR, Levin ED, Butcher LL . (1989b): Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic drugs. Psychopharmacology (Berl) 99: 371–373
Meltzer HY, McGurk SR . (1999): The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25: 233–255
Michal P, Lysikova M, El-Fakahany E, Stanislav T . (1999): Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors. Eur J Pharmacol 376: 119–125
Nowakowska E, Chodera A, Kus K, Rybakowski J . (1999): Some behavioural effects of risperidone in rats: comparison with haloperidol. Eur Neuropsychopharmacol 9: 421–426
Park T, Bae S, Choi S, Kang B, Kim K . (2001): Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells. Biochem Pharmacol 31: 1011–1019
Roussinov K, Yonkov D . (1976): Effect of imidazole, papeverine and histamine on learning and memory in albino rats. Acta Physiol Pharmacol Bulg 2: 49–57
Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE . (1996): Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124: 57–73
Sumiyoshi T, Kido H, Sakamoto H, Urasaki K, Suzuki K, Yamaguchi N, Mori H, Shiba K, Yokogawa K . (1994): In vivo dopamine-D2 and serotonin-5–HT2 receptor binding study of risperidone and haloperidol. Pharmacol Biochem Behav 47: 553–557
Wall P, Flinn J, Messier C . (2001): Infralimbic muscarinic M1 receptors modulate anxiety-like behaviors and spontaneous working memory in mice. Psychopharmacology (Berl) 155: 58–68
Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG . (1989): Presynaptic modulation of transmitter release by nicotinic receptors. In Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds), Progress In Brain Research. New York, Elsevier Science Publishers B.V., pp 157–163
Acknowledgements
This work was supported by National Institute on Drug Abuse grant # DA 11943 and a grant from the National Alliance for Research on Schizophrenia and Depression. We do not have conflict of interests with the makers of these antipsychotic drugs.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Addy, N., Levin, E. Nicotine Interactions with Haloperidol, Clozapine and Risperidone and Working Memory Function in Rats. Neuropsychopharmacol 27, 534–541 (2002). https://doi.org/10.1016/S0893-133X(02)00327-5
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(02)00327-5
Keywords
This article is cited by
-
Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
Neuropsychopharmacology (2012)
-
Nicotine Improves Working Memory Span Capacity in Rats Following Sub-Chronic Ketamine Exposure
Neuropsychopharmacology (2011)
-
Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine
Molecular Neurobiology (2008)
-
Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol
Psychopharmacology (2007)
-
Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task
Psychopharmacology (2007)
